- Conditions
- Pain, Postoperative, Amputation
- Interventions
- Liposomal bupivacaine, Bupivacaine Hydrochloride 0.5 % Injectable Solution
- Drug
- Lead sponsor
- Aurora Quaye
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- Portland, Maine
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–9
of 9
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Amputation
- Interventions
- Ropivacaine 0.2% + nerve stimulator set, Ropivacaine 0.2%
- Device · Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 3
- States / cities
- Stanford, California • Jacksonville, Florida • Iowa City, Iowa
- Conditions
- Knee Injuries
- Interventions
- Spinal Surgery, Verasense Knee System device
- Procedure · Device
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Peripheral Artery Disease, Critical Limb Ischemia
- Interventions
- Temsirolimus, Saline placebo
- Drug
- Lead sponsor
- Mercator MedSystems, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2032
- U.S. locations
- 2
- States / cities
- Houma, Louisiana • Dallas, Texas
- Conditions
- Peripheral Arterial Disease, Cardiovascular Disease, Peripheral Vascular Disease
- Interventions
- Paclitaxel administration using the OPC
- Other
- Lead sponsor
- Horizons International Peripheral Group
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 17
- States / cities
- Fairhope, Alabama • Jacksonville, Florida • Pensacola, Florida + 13 more
- Conditions
- Chronic Limb-Threatening Ischemia
- Interventions
- PCB, PTA
- Device
- Lead sponsor
- Acotec Scientific Co., Ltd
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 16
- States / cities
- Concord, California • Fremont, California • New Haven, Connecticut + 12 more
- Conditions
- Infrainguinal Peripheral Artery Disease, Peripheral Arterial Disease, PAD
- Interventions
- AURYON Atherectomy System
- Device
- Lead sponsor
- Angiodynamics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 10
- States / cities
- Scottsdale, Arizona • Tucson, Arizona • Davenport, Florida + 7 more
- Conditions
- Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial Disease
- Interventions
- MagicTouch PTA Sirolimus drug coated balloon, Placebo balloon angioplasty
- Device
- Lead sponsor
- Concept Medical Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 368 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 29
- States / cities
- Scottsdale, Arizona • Los Angeles, California • Clearwater, Florida + 22 more
- Conditions
- Cardiovascular Diseases, Peripheral Vascular Disease, Arterial Occlusive Diseases, Peripheral Arterial Disease, Critical Limb Ischemia
- Interventions
- Paclitaxel administration using the OPC
- Other
- Lead sponsor
- Horizons International Peripheral Group
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 4
- States / cities
- Fairhope, Alabama • Houma, Louisiana • Dearborn, Michigan + 1 more